Professor, Medicine, University of Pittsburgh School of Medicine
Gastroenterology
Dr. Miguel D. Regueiro, MD
|
|
Give Review
Doctor Miguel D. Regueiro, MD is an expert in the field of Gastroenterology. He researched medicine at Drexel University College of Medicine. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Fellow (AGAF)" and "Fellow (FACG)". Miguel D. Regueiro, MD is a published physician. He has 78 publications published. The most current publication "Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study." Dr. Miguel D. Regueiro accepts all Medicare patients.
Publications
- Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.
- Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.
- TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and Implementation of Randomized Clinical Trial.
- The Inflammatory Bowel Disease Live Interinstitutional and Interdisciplinary Videoconference Education (IBD LIVE) Series.
- IBD LIVE Case Series-Case 1: Smoking, a Controversial but Effective Treatment for Ulcerative Colitis.
- Stopping, Continuing, or Restarting Immunomodulators and Biologics When an Infection or Malignancy Develops.
- Association Between Telephone Activity and Features of Patients with Inflammatory Bowel Disease.
- Crohn's Disease With Worsening Symptoms.
- Pediatric autoimmune enteropathy: an entity frequently associated with immunodeficiency Disorders.
- Abdominal pain in ulcerative colitis.
- The great debate: stopping immunomodulators and biologics in Crohn's Disease patients in remission.
- Ultra-high C-reactive protein levels in hospitalized inflammatory bowel Disease (IBD) patients predicts serious complications.
- Mucosal IgG4 Cell Infiltration in Ulcerative Colitis Is Linked to Disease Activity and Primary Sclerosing Cholangitis.
- Tumor Necrosis Factor ? Antagonist-associated Psoriasis in Inflammatory Diseases: An Analysis of the FDA Adverse Event Reporting System.
- Relationship Between Proximal Crohn's Disease Location and Disease Behavior and Surgery: A Cross-Sectional Study of the IBD Genetics Consortium.
- Recurrent blood eosinophilia in ulcerative colitis is associated with severe Disease and primary sclerosing cholangitis.
- The evolving management of postoperative Crohn's Disease.
- An Unusual Cause of Melena and Abdominal Pain.
- An unusual cause of lower gastrointestinal bleeding in Crohn's Disease.
- Evaluation for postoperative recurrence of crohn Disease.
- PUMA-mediated Intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice.
- Management and prevention of postoperative Crohn's Disease.
- Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study.
- Diagnosis and treatment of Ulcerative proctitis.
- Metabolic bone Disease in inflammatory bowel Disease.
- Inflammatory bowel Disease emergencies.
- Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic Syndrome.
- Medical therapy for Ulcerative colitis.
- Pregnancy and nursing in inflammatory bowel Disease.
- Austronesian genetic signature in East African Madagascar and Polynesia.
- Renal dysfunction after orthotopic heart transplantation: incidence, natural history, and risk factors.
- Male amelogenin dropouts: phylogenetic context, origins and implications.
- Fine needle aspiration cytology of a pancreatic cyst in a patient with autosomal dominant polycystic kidney Disease. A case report.
- Will the real 5-aminosalicylic acid please stand up?
- Update in medical treatment of Crohn's Disease.
- Management of persistent Gastric bleeding in a patient with Glanzmann's thrombasthenia.
- Postoperative management of crohn Disease.
- How we manage challenging inflammatory bowel Disease. Preface.
- Small bowel resection rates in Crohn's Disease and the indication for surgery over time: experience from a large tertiary care center.
- Phenotypic and genotypic characteristics of inflammatory bowel Disease in French Canadians: comparison with a large North American repository.
- Postoperative Crohn''s Disease: prevention and treatment.
- Postoperative infliximab is not associated with an increase in adverse events in Crohn's Disease.
- Stopping immunomodulators and biologics in inflammatory bowel Disease patients in remission.
- Clinical course of Crohn's Disease following treatment of lymphoma.
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's Disease susceptibility loci.
- Prevention and treatment of postoperative Crohn's Disease recurrence: an update for a new decade.
- Crohn's Disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection.
- Physician assessment of ulcerative colitis activity correlates poorly with endoscopic Disease activity.
- Postoperative Crohn''s Disease: how can we prevent it?
- Preventive therapy in postoperative Crohn's Disease.
- Challenges in inflammatory bowel Disease. Preface.
- Pathologic features of early inflammatory bowel Disease.
- Segmental colitis associated with Diverticulosis.
- The role of endoscopy in the evaluation of fistulizing Crohn's Disease.
- Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's Disease.
- Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel Disease.
- Treatment of perianal fistulizing Crohn's Disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
- Inflammatory bowel Disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
- Cigarette smoking and age at diagnosis of inflammatory bowel Disease.
- Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel Disease.
- Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel Disease.
- Infliximab dose intensification in Crohn's Disease.
- Genome-wide association study identifies new susceptibility loci for Crohn Disease and implicates autophagy in Disease pathogenesis.
- Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium ...
- A genome-wide association study identifies IL23R as an inflammatory bowel Disease gene.
- Systemic mastocytosis mimicking inflammatory bowel disease: A case report and discussion of gastrointestinal pathology in Systemic mastocytosis.
- Medical management of left-sided Ulcerative colitis and Ulcerative proctitis: critical evaluation of therapeutic trials.
- Clinical guidelines for the medical management of left-sided Ulcerative colitis and Ulcerative proctitis: summary statement.
- Infliximab for hospitalized patients with severe Ulcerative colitis.
- Intravenous cyclosporine in severe Ulcerative colitis: how low can you go?
- A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory Ulcerative colitis.
- Infliximab prevents Crohn's Disease recurrence after ileal resection.
- Radiologic testing in Crohn's Disease.
- Management of perianal fistula in Crohn's Disease.
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn''s Disease.
- Protein-tyrosine phosphatase sigma is associated with Ulcerative colitis.
- Common variants at five new loci associated with early-onset inflammatory bowel Disease.
Schools
Hahnemann University
Beth Israel Hospital Harvard Med School
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
- Fellow (FACG)
Education
-
Beth Israel Deaconess Medical Center -
Drexel University College of Medicine
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1649245788 | |
| NPPES Provider LastName | REGUEIRO | |
| NPPES Provider FirstName | MIGUEL | |
| NPPES Provider ZIPCode | 152132546 | |
| NPPES Provider State | PA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 983.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649245788 |
| Last Name Of The Provider | REGUEIRO |
| First Name Of The Provider | MIGUEL |
| View All |
Similar Doctors
|
|
Dr. Joseph P. Pusateri Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhijit Kulkarni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xuong C. Lu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George L. Arnold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Mulock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yisrael A. Isaacson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet R. Harrison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Limauro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Maneesha A. Pradhan, PA-C |